Melitracen

Melitracen

SCHEMBL29984590

CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 8/20 1.00
SLC6A2 P23975 7/20 1.00
KCNH2 Q12809 7/20 1.00
HTR2B P41595 6/20 1.00
CHRM2 P08172 6/20 1.00
CHRM1 P11229 6/20 1.00
DRD2 P14416 6/20 1.00
SLC6A4 P31645 6/20 1.00
ADRA1A P35348 6/20 1.00
DRD3 P35462 6/20 1.00
ADRA2C P18825 5/20 1.00
CHRM3 P20309 5/20 1.00
HTR2A P28223 5/20 1.00
HTR2C P28335 5/20 1.00
HTR1A P08908 5/20 1.00
ADRA2A P08913 5/20 1.00
ADRA2B P18089 4/20 1.00
DRD1 P21728 4/20 1.00
MC3R P41968 4/20 1.00
HRH3 Q9Y5N1 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Melitracen SCHEMBL48975 1.00 HRH1 (1.00) HRH1SLC6A2KCNH2HTR2BCHRM2
Melitracen SCHEMBL121493 0.98 HRH1 (0.97) HRH1SLC6A2KCNH2HTR2BCHRM2
Melitracen SCHEMBL29399425 0.98 HRH1 (0.97) HRH1SLC6A2KCNH2HTR2BCHRM2
Melitracen SCHEMBL2473296 0.98 HRH1 (0.97) HRH1SLC6A2KCNH2HTR2BCHRM2
Melitracen SCHEMBL1650139 0.97 HRH1 (0.94) HRH1SLC6A2KCNH2HTR2BCHRM2
Melitracen SCHEMBL29195738 0.97 HRH1 (0.94) HRH1SLC6A2KCNH2HTR2BCHRM2
Litracen SCHEMBL2109078 0.77 SLC6A2 (0.62) HRH1SLC6A2KCNH2HTR2BCHRM2
Cyclobenzaprine SCHEMBL38527 0.76 HRH1 (1.00) HRH1SLC6A2KCNH2HTR2BCHRM2
Cyclobenzaprine SCHEMBL29520569 0.76 HRH1 (1.00) HRH1SLC6A2KCNH2HTR2BCHRM2
Cyclobenzaprine SCHEMBL7654526 0.76 HRH1 (1.00) HRH1SLC6A2KCNH2HTR2BCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262247-A1 TREATMENT OF HEADACHE DISORDERS AND/OR PSYCHIATRIC SYMPTOMS USING ANTI-CGRP ANTIBODIES, AND COMPOSITIONS AND METHODS RELATED THERETO H. LUNDBECK A/S (DK) 2025-12-26 WO disclosed
WO-2024197124-A9 ARGININE VASOPRESSIN RECEPTOR (AVPR) ANTAGONISTS AND METHODS OF USING THEREOF UNIVERSITY OF MIAMI (US) 2024-12-19 WO disclosed
WO-2024197124-A2 ARGININE VASOPRESSIN RECEPTOR (AVPR) ANTAGONISTS AND METHODS OF USING THEREOF UNIVERSITY OF MIAMI (US) 2024-09-26 WO disclosed
CN-112300119-B Metliquxin and flupentixol eutectic and preparation method thereof 苏州恩华生物医药科技有限公司 2024-04-16 CN disclosed
CN-115417753-A Synthetic method of melitracen and intermediate thereof 重庆西南制药二厂有限责任公司 2022-12-02 CN disclosed
WO-2022198003-A1 NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 VANDERBILT UNIVERSITY (US) 2022-09-22 WO disclosed